SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001144204-13-048827
Filing Date
2013-08-30
Accepted
2013-08-30 17:02:36
Documents
3
Period of Report
2013-08-29
Items
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.01: Changes in Control of Registrant
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K v354048_8k.htm 8-K 30916
2 EX-3.1 v354048_ex3-1.htm EX-3.1 9921
3 EX-3.2 v354048_ex3-2.htm EX-3.2 44381
  Complete submission text file 0001144204-13-048827.txt   86882
Mailing Address 3 SAPIR STREET WEIZMANN SCIENCE PARK NES-ZIONA L3 74140
Business Address 3 SAPIR STREET WEIZMANN SCIENCE PARK NES-ZIONA L3 74140 (866) 644-7811
PROLOR Biotech, Inc. (Filer) CIK: 0001268659 (see all company filings)

IRS No.: 000000000 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34676 | Film No.: 131072988
SIC: 2834 Pharmaceutical Preparations